The mechanisms of atrial fibrillation in hyperthyroidism

Bielecka-Dabrowa, Agata; Mikhailidis, Dimitri P.; Rysz, Jacek; Banach, Maciej
January 2009
Thyroid Research;2009, Vol. 2, p1
Academic Journal
Atrial fibrillation (AF) is a complex condition with several possible contributing factors. The rapid and irregular heartbeat produced by AF increases the risk of blood clot formation inside the heart. These clots may eventually become dislodged, causing embolism, stroke and other disorders. AF occurs in up to 15% of patients with hyperthyroidism compared to 4% of people in the general population and is more common in men and in patients with triiodothyronine (T3) toxicosis. The incidence of AF increases with advancing age. Also, subclinical hyperthyroidism is a risk factor associated with a 3-fold increase in development of AF. Thyrotoxicosis exerts marked influences on electrical impulse generation (chronotropic effect) and conduction (dromotropic effect). Several potential mechanisms could be invoked for the effect of thyroid hormones on AF risk, including elevation of left atrial pressure secondary to increased left ventricular mass and impaired ventricular relaxation, ischemia resulting from increased resting heart rate, and increased atrial eopic activity. Reentry has been postulated as one of the main mechanisms leading to AF. AF is more likely if effective refractory periods are short and conduction is slow. Hyperthyroidism is associated with shortening of action potential duration which may also contribute to AF.


Related Articles

  • Plasma levels of coagulation and fibrinolysis markers in acute ischemic stroke patients with lone atrial fibrillation. Topcuoglu, M.A.; Haydari, D.; Ozturk, S.; Ozcebe, O.I.; Saribas, O. // Neurological Sciences;Aug2000, Vol. 21 Issue 4, p235 

    Atrial fibrillation (AF) is a well-defined risk factor for ischemic stroke. Patients with lone AF represent a subgroup of AF patients with the lowest lifelong stroke risk. Nonvalvular atrial fibrillation (NVAF) confers a hypercoagulable state resulting in an increased risk of thromboembolism....

  • GP REGISTRAR: Pass Notes - Atrial fibrillation - part one. Newson, Louise // GP: General Practitioner;11/17/2003, p69 

    Atrial fibrillation (AF) affects about 10 per cent of people over the age of 75. Patients with AF who sustain a stroke have a higher mortality rate, greater disability, a longer duration of hospital stay and a lower rate of discharge to their own home. It is recommended that patients who are at...

  • Anticoagulation Risks in Atrial Fibrillation. Zepf, Bill // American Family Physician;4/1/2004, Vol. 69 Issue 7, p1792 

    Discusses research being done on the relationship between anticoagulation intensity and stroke frequency, severity and mortality in patients with atrial fibrillation. Reference to a study by E.M. Hylek and colleagues, published in the September 11, 2003 issue of "New England Journal of...

  • The Increasing Need for Anticoagulant Therapy to Prevent Stroke in Patients With Atrial Fibrillation. Ezekowitz, Michael D.; Falk, Rodney H. // Mayo Clinic Proceedings;Jul2004, Vol. 79 Issue 7, p904 

    Ischemic stroke, a major complication of atrial fibrillation (AF), is believed to result from atrial thrombus formation caused by ineffective atrial contraction. Oral anticoagulant therapy effectively reduces the risk of ischemic stroke in patients with AF, this therapy is recommended for...

  • Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. Stollberger, Claudia; Chnupa, Pavel; Kronik, Gerhard; Brainin, Michael; Finsterer, Josef; Schneider, Barbara; Slany, Jörg // Annals of Internal Medicine;04/15/98, Vol. 128 Issue 8, p630 

    Presents a study which examined the association of transesophageal echocardiographic characteristics with stroke or embolism in atrial fibrillation. Information on transesophageal echocardiography; Participants in this study; Method employed in this study; Results of this study.

  • Assessment of association of rs2200733 on chromosome 4q25 with atrial fibrillation and ischemic stroke in a Chinese Han population. Lisong Shi; Cong Li; Chuchu Wang; Yunlong Xia; Gang Wu; Fan Wang; Chengqi Xu; Pengyun Wang; Xiuchun Li; Dan Wang; Xin Xiong; Ying Bai; Mugen Liu; Jingyu Liu; Xiang Ren; Lianjun Gao; Binbin Wang; Qiutang Zeng; Bo Yang; Xu Ma // Human Genetics;Dec2009, Vol. 126 Issue 6, p843 

    Atrial fibrillation (AF) is the most common arrhythmia in the clinical setting and an independent risk factor for stroke. Approximately 10 million Chinese people are affected by AF, but the genetic basis is largely unknown. A recent genome-wide association study in Iceland identified association...

  • Stroke due to atrial fibrillation and the attitude to prescribing anticoagulant prevention in Italy. Gandolfo, C.; Balestrino, M.; Burrone, A.; Sette, M.; Finocchi, C. // Journal of Neurology;Jun2008, Vol. 255 Issue 6, p796 

    Several studies have reported that oral anticoagulant prophylaxis (OAC) is under-used in patients with atrial fibrillation (AF). This study investigated the attitude to prescribing OAC in patients with AF observed in an Italian Stroke Unit (SU) and the severity of ischemic stroke due to AF in...

  • Secondary Stroke Prevention in Patients with Cryptogenic Stroke and Patent Foramen Ovale. Belvís, Robert; Martí-Fàbregas, Joan; Cocho, Dolores; Martí-Vilalta, Josep Lluis // Vascular Disease Prevention;Apr2006, Vol. 3 Issue 2, p129 

    The foramen ovale is an ellipsoidal-shaped tunnel in the interatrial septum of the foetal heart allowing a rightto- left shunt between the two atria. It generally closes soon after birth but remains permeable in about 30% of adults. The frequency of this patent foramen ovale (PFO) in stroke...

  • Diabetes and Thyroid Hormones Affect Connexin-43 and PKC-ϵ Expression in Rat Heart Atria. Mitašíková, M.; Lin, H.; Soukup, T.; Imanaga, I.; Tribulová, N. // Physiological Research;2009, Vol. 58 Issue 2, p211 

    We have examined the changes of intercellular electrical coupling protein connexin-43 (Cx43) and of PKC-ϵ in heart atria of diabetic rats and/or after the treatment with triiodothyronine (T3). Diabetes was induced in Wistar-Kyoto rats by streptozotocin (50 mg/kg, i.v.) and atria were examined...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics